Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 567

1.

Undisturbed stance on a double seesaw: Interaction between asymmetries of the center-of-pressure patterns under each foot and weight-bearing.

Rougier P, Ankaoua C, Paillard T, Coquard T, Dury J, Barthod C, Perennou D.

J Biomech. 2019 Jun 11;90:113-118. doi: 10.1016/j.jbiomech.2019.04.041. Epub 2019 May 4.

PMID:
31088752
2.

Upright standing after stroke: How loading-unloading mechanism participates to the postural stabilization.

Rougier PR, Pérennou D.

Hum Mov Sci. 2019 Apr;64:47-54. doi: 10.1016/j.humov.2019.01.004. Epub 2019 Jan 15.

PMID:
30658239
3.

Biomechanical Study of Tandem Stance in Healthy Young Adults: Effects of Weight-Bearing and Limb Dominance.

Rougier PR, Marsande J, James M, Brachet M.

J Mot Behav. 2019;51(6):603-609. doi: 10.1080/00222895.2018.1545217. Epub 2019 Jan 2.

PMID:
30600782
4.

Postural control in healthy young adults using a double seesaw device.

Rougier PR, Perennou D.

J Biomech. 2019 Jan 23;83:214-220. doi: 10.1016/j.jbiomech.2018.11.048. Epub 2018 Dec 5.

PMID:
30573303
5.

Attentional cost in additional visual feedback protocols in healthy young subjects.

Rougier PR, Fleury PH, Tollenaere B.

Exp Brain Res. 2019 Feb;237(2):547-555. doi: 10.1007/s00221-018-5433-x. Epub 2018 Nov 27.

PMID:
30483829
6.

Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials.

Aparicio T, Ducreux M, Faroux R, Barbier E, Manfredi S, Lecomte T, Etienne PL, Bedenne L, Bennouna J, Phelip JM, François E, Michel P, Legoux JL, Gasmi M, Breysacher G, Rougier P, De Gramont A, Lepage C, Bouché O, Seitz JF; for FFCD investigators.

Eur J Cancer. 2018 Jul;98:1-9. doi: 10.1016/j.ejca.2018.03.031. Epub 2018 May 26.

7.

Phase III randomized trial comparing 5-fluorouracil and oxaliplatin with or without docetaxel in first-line advanced gastric cancer chemotherapy (GASTFOX study).

Zaanan A, Samalin E, Aparicio T, Bouche O, Laurent-Puig P, Manfredi S, Michel P, Monterymard C, Moreau M, Rougier P, Tougeron D, Taieb J, Louvet C.

Dig Liver Dis. 2018 Apr;50(4):408-410. doi: 10.1016/j.dld.2018.01.119. Epub 2018 Mar 1.

PMID:
29409778
8.

Hepatic arterial infusion in the management of colorectal cancer liver metastasis: Current and future perspectives.

Chapelle N, Matysiak-Budnik T, Douane F, Metairie S, Rougier P, Touchefeu Y.

Dig Liver Dis. 2018 Mar;50(3):220-225. doi: 10.1016/j.dld.2017.12.004. Epub 2017 Dec 14. Review.

PMID:
29290599
9.

Improving Outcomes in Patients with CRC: The Role of Patient Reported Outcomes-An ESDO Report.

Van Cutsem E, De Gramont A, Henning G, Rougier P, Bonnetain F, Seufferlein T.

Cancers (Basel). 2017 May 26;9(6). pii: E59. doi: 10.3390/cancers9060059. Review.

10.

Influence of slope steepness, foot position and turn phase on plantar pressure distribution during giant slalom alpine ski racing.

Falda-Buscaiot T, Hintzy F, Rougier P, Lacouture P, Coulmy N.

PLoS One. 2017 May 4;12(5):e0176975. doi: 10.1371/journal.pone.0176975. eCollection 2017.

11.

A need to simplify informed consent documents in cancer clinical trials. A position paper of the ARCAD Group.

Bleiberg H, Decoster G, de Gramont A, Rougier P, Sobrero A, Benson A, Chibaudel B, Douillard JY, Eng C, Fuchs C, Fujii M, Labianca R, Larsen AK, Mitchell E, Schmoll HJ, Sprumont D, Zalcberg J.

Ann Oncol. 2017 May 1;28(5):922-930. doi: 10.1093/annonc/mdx050.

12.

Hepatic Arterial Infusion Chemotherapy for Unresectable Liver Metastases of Colorectal Cancer: A Multicenter Retrospective Study.

Lim A, Le Sourd S, Senellart H, Luet D, Douane F, Perret C, Bouvier A, Métairie S, Cauchin E, Rougier P, Matysiak-Budnik T, Touchefeu Y.

Clin Colorectal Cancer. 2017 Dec;16(4):308-315. doi: 10.1016/j.clcc.2017.03.003. Epub 2017 Mar 14.

PMID:
28433600
13.

Interaction between postural asymmetry and visual feedback effects in undisturbed upright stance control in healthy adults.

Rougier PR, Boudrahem S.

Neurophysiol Clin. 2017 Sep;47(4):305-314. doi: 10.1016/j.neucli.2017.01.010. Epub 2017 Mar 15.

PMID:
28314520
14.

Erratum to: Chemoembolization of Neuroendocrine Liver Metastases Using Streptozocin and Tris-acryl Microspheres: Embozar (EMBOsphere + ZAnosaR) Study.

Pelage JP, Fohlen A, Mitry E, Lagrange C, Beauchet A, Rougier P.

Cardiovasc Intervent Radiol. 2017 Mar;40(3):480. doi: 10.1007/s00270-017-1573-9. No abstract available.

PMID:
28101615
15.

Chemoembolization of Neuroendocrine Liver Metastases Using Streptozocin and Tris-acryl Microspheres: Embozar (EMBOsphere + ZAnosaR) Study.

Pelage JP, Fohlen A, Mitry E, Lagrange C, Beauchet A, Rougier P.

Cardiovasc Intervent Radiol. 2017 Mar;40(3):394-400. doi: 10.1007/s00270-016-1535-7. Epub 2016 Dec 29. Erratum in: Cardiovasc Intervent Radiol. 2017 Mar;40(3):480.

PMID:
28035432
16.

The multidisciplinary management of gastro-oesophageal junction tumours: European Society of Digestive Oncology (ESDO): Expert discussion and report from the 16th ESMO World Congress on Gastrointestinal Cancer, Barcelona.

Van Laethem JL, Carneiro F, Ducreux M, Messman H, Lordick F, Ilson DH, Allum WH, Haustermans K, Lepage C, Matysiak-Budnik T, Cats A, Schmiegel W, Cervantes A, Van Cutsem E, Rougier P, Seufferlein T.

Dig Liver Dis. 2016 Nov;48(11):1283-1289. doi: 10.1016/j.dld.2016.08.112. Epub 2016 Aug 20.

PMID:
27590840
17.

Early tumour response as a survival predictor in previously- treated patients receiving triplet hepatic artery infusion and intravenous cetuximab for unresectable liver metastases from wild-type KRAS colorectal cancer.

Bouchahda M, Boige V, Smith D, Karaboué A, Ducreux M, Hebbar M, Lepère C, Focan C, Guimbaud R, Innominato P, Awad S, Carvalho C, Tumolo S, Truant S, De Baere T, Castaing D, Rougier P, Morère JF, Taieb J, Adam R, Lévi F; ARTBC International.

Eur J Cancer. 2016 Nov;68:163-172. doi: 10.1016/j.ejca.2016.09.011. Epub 2016 Oct 18.

PMID:
27768923
18.

Imaging in Colorectal Cancer: Progress and Challenges for the Clinicians.

Van Cutsem E, Verheul HM, Flamen P, Rougier P, Beets-Tan R, Glynne-Jones R, Seufferlein T.

Cancers (Basel). 2016 Aug 31;8(9). pii: E81. doi: 10.3390/cancers8090081. Review.

19.

Emergency therapy for liver metastases from advanced VIPoma: surgery or transarterial chemoembolization?

Dréanic J, Lepère C, El Hajjam M, Gouya H, Rougier P, Coriat R.

Ther Adv Med Oncol. 2016 Sep;8(5):383-7. doi: 10.1177/1758834016656495. Epub 2016 Jul 5. Review.

20.

How does wearing a lumbar orthosis interfere with gait initiation?

Cusin E, Do MC, Rougier PR.

Ergonomics. 2017 Jun;60(6):837-843. doi: 10.1080/00140139.2016.1206214. Epub 2016 Jul 12.

PMID:
27403814
21.

Treatment sequence of synchronously (liver) metastasized colon cancer.

Gruenberger T, Beets G, Van Laethem JL, Rougier P, Cervantes A, Douillard JY, Figueras J, Gruenberger B, Haller DG, Labianca R, Maleux G, Roth A, Ducreux M, Schmiegel W, Seufferlein T, Van Cutsem E.

Dig Liver Dis. 2016 Oct;48(10):1119-23. doi: 10.1016/j.dld.2016.06.009. Epub 2016 Jun 17. Review.

PMID:
27375207
22.

How providing more or less time to solve a cognitive task interferes with upright stance control; a posturographic analysis on healthy young adults.

Rougier PR, Bonnet CT.

Hum Mov Sci. 2016 Jun;47:106-115. doi: 10.1016/j.humov.2016.03.001. Epub 2016 Mar 4.

PMID:
26949920
23.

Efficacy of modern chemotherapy and prognostic factors in patients with ovarian metastases from gastric cancer: A retrospective AGEO multicentre study.

Brieau B, Auzolle C, Pozet A, Tougeron D, Bouché O, Soibinet P, Coriat R, Prieux C, Lecomte T, Goujon G, Marthey L, Rougier P, Bonnetain F, Ducreux M, Taieb J, Zaanan A.

Dig Liver Dis. 2016 Apr;48(4):441-5. doi: 10.1016/j.dld.2015.12.012. Epub 2015 Dec 29.

PMID:
26775096
24.

Quality-of-life and performance status results from the phase III RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinoma.

Al-Batran SE, Van Cutsem E, Oh SC, Bodoky G, Shimada Y, Hironaka S, Sugimoto N, Lipatov ON, Kim TY, Cunningham D, Rougier P, Muro K, Liepa AM, Chandrawansa K, Emig M, Ohtsu A, Wilke H.

Ann Oncol. 2016 Apr;27(4):673-9. doi: 10.1093/annonc/mdv625. Epub 2016 Jan 7.

25.

Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV.

Lévi FA, Boige V, Hebbar M, Smith D, Lepère C, Focan C, Karaboué A, Guimbaud R, Carvalho C, Tumolo S, Innominato P, Ajavon Y, Truant S, Castaing D, De Baere T, Kunstlinger F, Bouchahda M, Afshar M, Rougier P, Adam R, Ducreux M; Association Internationale pour Recherche sur Temps Biologique et Chronothérapie (ARTBC International).

Ann Oncol. 2016 Feb;27(2):267-74. doi: 10.1093/annonc/mdv548. Epub 2015 Nov 16.

PMID:
26578731
26.

Radiochemotherapy Versus Surgery in Nonmetastatic Anorectal Neuroendocrine Carcinoma: A Multicenter Study by the Association des Gastro-Entérologues Oncologues.

Brieau B, Lepère C, Walter T, Lecomte T, Guimbaud R, Manfredi S, Tougeron D, Desseigne F, Lourenco N, Afchain P, El Hajbi F, Terris B, Rougier P, Coriat R.

Medicine (Baltimore). 2015 Oct;94(42):e1864. doi: 10.1097/MD.0000000000001864.

27.

High-Dose FOLFIRI plus Bevacizumab in the Treatment of Metastatic Colorectal Cancer Patients with Two Different UGT1A1 Genotypes: FFCD 0504 Study.

Manfredi S, Bouché O, Rougier P, Dahan L, Loriot MA, Aparicio T, Etienne PL, Lafargue JP, Lécaille C, Legoux JL, Le Malicot K, Maillard E, Lecomte T, Khemissa F, Breysacher G, Michel P, Mitry E, Bedenne L.

Mol Cancer Ther. 2015 Dec;14(12):2782-8. doi: 10.1158/1535-7163.MCT-15-0293. Epub 2015 Oct 22.

28.

Walking with eyes closed is easier than walking with eyes open without visual cues: The Romberg task versus the goggle task.

Yelnik AP, Tasseel Ponche S, Andriantsifanetra C, Provost C, Calvalido A, Rougier P.

Ann Phys Rehabil Med. 2015 Dec;58(6):332-5. doi: 10.1016/j.rehab.2015.08.004. Epub 2015 Oct 2.

29.

Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus.

Adam R, de Gramont A, Figueras J, Kokudo N, Kunstlinger F, Loyer E, Poston G, Rougier P, Rubbia-Brandt L, Sobrero A, Teh C, Tejpar S, Van Cutsem E, Vauthey JN, Påhlman L; of the EGOSLIM (Expert Group on OncoSurgery management of LIver Metastases) group.

Cancer Treat Rev. 2015 Nov;41(9):729-41. doi: 10.1016/j.ctrv.2015.06.006. Epub 2015 Jun 30. Review.

30.

Reply to E.C. Smyth et al and E. Elimova et al.

Guimbaud R, Louvet C, Ychou M, Bouché O, Rougier P.

J Clin Oncol. 2015 Jul 20;33(21):2410-1. doi: 10.1200/JCO.2014.60.5550. Epub 2015 Jun 15. No abstract available.

PMID:
26077234
31.

Postoperative irinotecan in resected stage II-III rectal cancer: final analysis of the French R98 Intergroup trial†.

Delbaldo C, Ychou M, Zawadi A, Douillard JY, André T, Guerin-Meyer V, Rougier P, Dupuis O, Faroux R, Jouhaud A, Quinaux E, Buyse M, Piedbois P; AERO, GERCOR, FNLCC and FFCD.

Ann Oncol. 2015 Jun;26(6):1208-15. doi: 10.1093/annonc/mdv135. Epub 2015 Mar 3.

PMID:
25739671
32.

Prognostic score for recurrence after Whipple's pancreaticoduodenectomy for ampullary carcinomas; results of an AGEO retrospective multicenter cohort.

Colussi O, Voron T, Pozet A, Hammel P, Sauvanet A, Bachet JB, Vaillant JC, Rougier P, Nordlinger B, Berger A, Coriat R, Dousset B, Malka D, André T, Paye F, Aparicio T, Locher C, Cojean Zeleck D, Tchinou L, Bonnetain F, Taieb J.

Eur J Surg Oncol. 2015 Apr;41(4):520-6. doi: 10.1016/j.ejso.2015.01.010. Epub 2015 Jan 24.

PMID:
25680954
33.

Fluorouracil, leucovorin, and irinotecan plus cetuximab treatment and RAS mutations in colorectal cancer.

Van Cutsem E, Lenz HJ, Köhne CH, Heinemann V, Tejpar S, Melezínek I, Beier F, Stroh C, Rougier P, van Krieken JH, Ciardiello F.

J Clin Oncol. 2015 Mar 1;33(7):692-700. doi: 10.1200/JCO.2014.59.4812. Epub 2015 Jan 20.

PMID:
25605843
34.

Bevacizumab plus capecitabine in patients with progressive advanced well-differentiated neuroendocrine tumors of the gastro-intestinal (GI-NETs) tract (BETTER trial)--a phase II non-randomised trial.

Mitry E, Walter T, Baudin E, Kurtz JE, Ruszniewski P, Dominguez-Tinajero S, Bengrine-Lefevre L, Cadiot G, Dromain C, Farace F, Rougier P, Ducreux M.

Eur J Cancer. 2014 Dec;50(18):3107-15. doi: 10.1016/j.ejca.2014.10.001. Epub 2014 Oct 18.

PMID:
25454413
35.

Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study.

Van Cutsem E, Boni C, Tabernero J, Massuti B, Middleton G, Dane F, Reichardt P, Pimentel FL, Cohn A, Follana P, Clemens M, Zaniboni A, Moiseyenko V, Harrison M, Richards DA, Prenen H, Pernot S, Ecstein-Fraisse E, Hitier S, Rougier P.

Ann Oncol. 2015 Jan;26(1):149-56.

PMID:
25416687
36.

Prospective, randomized, multicenter, phase III study of fluorouracil, leucovorin, and irinotecan versus epirubicin, cisplatin, and capecitabine in advanced gastric adenocarcinoma: a French intergroup (Fédération Francophone de Cancérologie Digestive, Fédération Nationale des Centres de Lutte Contre le Cancer, and Groupe Coopérateur Multidisciplinaire en Oncologie) study.

Guimbaud R, Louvet C, Ries P, Ychou M, Maillard E, André T, Gornet JM, Aparicio T, Nguyen S, Azzedine A, Etienne PL, Boucher E, Rebischung C, Hammel P, Rougier P, Bedenne L, Bouché O.

J Clin Oncol. 2014 Nov 1;32(31):3520-6. doi: 10.1200/JCO.2013.54.1011. Epub 2014 Oct 6. Erratum in: J Clin Oncol. 2015 Apr 20;33(12):1416.

PMID:
25287828
37.

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial.

Wilke H, Muro K, Van Cutsem E, Oh SC, Bodoky G, Shimada Y, Hironaka S, Sugimoto N, Lipatov O, Kim TY, Cunningham D, Rougier P, Komatsu Y, Ajani J, Emig M, Carlesi R, Ferry D, Chandrawansa K, Schwartz JD, Ohtsu A; RAINBOW Study Group.

Lancet Oncol. 2014 Oct;15(11):1224-35. doi: 10.1016/S1470-2045(14)70420-6. Epub 2014 Sep 17.

PMID:
25240821
38.

Postural mechanisms to control body displacements in the performance of lateral gaze shifts.

Bonnet CT, Morio C, Szaffarczyk S, Rougier PR.

J Mot Behav. 2014;46(6):397-405. doi: 10.1080/00222895.2014.924472. Epub 2014 Sep 10.

PMID:
25207952
39.

Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial.

Taieb J, Tabernero J, Mini E, Subtil F, Folprecht G, Van Laethem JL, Thaler J, Bridgewater J, Petersen LN, Blons H, Collette L, Van Cutsem E, Rougier P, Salazar R, Bedenne L, Emile JF, Laurent-Puig P, Lepage C; PETACC-8 Study Investigators.

Lancet Oncol. 2014 Jul;15(8):862-73. doi: 10.1016/S1470-2045(14)70227-X. Epub 2014 Jun 11.

40.

Management of patients over 80 years of age treated with resection for localised colon cancer: results from a French referral centre.

Lièvre A, Laurent V, Cudennec T, Peschaud F, Malafosse R, Benoist S, Penna C, Lepère C, Vaillant JN, Julié C, Teillet L, Nordlinger B, Rougier P, Mitry E.

Dig Liver Dis. 2014 Sep;46(9):838-45. doi: 10.1016/j.dld.2014.05.005. Epub 2014 Jun 5.

PMID:
24908573
41.

The contribution of body weight distribution and center of pressure location in the control of mediolateral stance.

Bonnet CT, Cherraf S, Szaffarczyk S, Rougier PR.

J Biomech. 2014 May 7;47(7):1603-8. doi: 10.1016/j.jbiomech.2014.03.005. Epub 2014 Mar 12.

PMID:
24679709
42.

Sustained response with gemcitabine plus Nab-paclitaxel after folfirinox failure in metastatic pancreatic cancer: report of an effective new strategy.

Portal A, Pernot S, Siauve N, Landi B, Lepère C, Colussi O, Rougier P, Zaanan A, Verrière B, Taieb J.

Clin Res Hepatol Gastroenterol. 2014 Apr;38(2):e23-6. doi: 10.1016/j.clinre.2014.01.005. Epub 2014 Feb 18.

PMID:
24559766
43.

Chemotherapy versus self-expanding metal stent as primary treatment of severe dysphagia from unresectable oesophageal or gastro-oesophageal junction cancer.

Touchefeu Y, Archambeaud I, Landi B, Lièvre A, Lepère C, Rougier P, Mitry E.

Dig Liver Dis. 2014 Mar;46(3):283-6. doi: 10.1016/j.dld.2013.10.012. Epub 2013 Nov 20.

PMID:
24268567
44.

Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial.

Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, Jaeck D, Mirza D, Parks RW, Mauer M, Tanis E, Van Cutsem E, Scheithauer W, Gruenberger T; EORTC Gastro-Intestinal Tract Cancer Group; Cancer Research UK; Arbeitsgruppe Lebermetastasen und–tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO); Australasian Gastro-Intestinal Trials Group (AGITG); Fédération Francophone de Cancérologie Digestive (FFCD).

Lancet Oncol. 2013 Nov;14(12):1208-15. doi: 10.1016/S1470-2045(13)70447-9. Epub 2013 Oct 11.

PMID:
24120480
45.

Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis.

Oba K, Paoletti X, Alberts S, Bang YJ, Benedetti J, Bleiberg H, Catalano P, Lordick F, Michiels S, Morita S, Ohashi Y, Pignon JP, Rougier P, Sasako M, Sakamoto J, Sargent D, Shitara K, Cutsem EV, Buyse M, Burzykowski T; GASTRIC group.

J Natl Cancer Inst. 2013 Nov 6;105(21):1600-7. doi: 10.1093/jnci/djt270. Epub 2013 Oct 9. Review.

46.

Progression-free survival as a surrogate for overall survival in advanced/recurrent gastric cancer trials: a meta-analysis.

Paoletti X, Oba K, Bang YJ, Bleiberg H, Boku N, Bouché O, Catalano P, Fuse N, Michiels S, Moehler M, Morita S, Ohashi Y, Ohtsu A, Roth A, Rougier P, Sakamoto J, Sargent D, Sasako M, Shitara K, Thuss-Patience P, Van Cutsem E, Burzykowski T, Buyse M; GASTRIC group.

J Natl Cancer Inst. 2013 Nov 6;105(21):1667-70. doi: 10.1093/jnci/djt269. Epub 2013 Oct 9.

47.

[What is the contribution of tumor response in colorectal cancer?].

Bachet JB, Paoletti X, Fournier L, Rougier P.

Bull Cancer. 2013 Jul-Aug;100(7-8):743-55. doi: 10.1684/bdc.2013.1780. Review. French.

PMID:
23831844
48.

Biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: safety and efficacy in a multicenter cohort.

Pernot S, Mitry E, Samalin E, Dahan L, Dalban C, Ychou M, Seitz JF, Turki H, Mazard T, Zaanan A, Lepère C, Vaillant JN, Landi B, Rougier P, Taieb J.

Gastric Cancer. 2014 Apr;17(2):341-7. doi: 10.1007/s10120-013-0266-6. Epub 2013 Jun 6.

PMID:
23739764
49.

Randomised, placebo-controlled, double-blind, parallel-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancer.

Rougier P, Riess H, Manges R, Karasek P, Humblet Y, Barone C, Santoro A, Assadourian S, Hatteville L, Philip PA.

Eur J Cancer. 2013 Aug;49(12):2633-42. doi: 10.1016/j.ejca.2013.04.002. Epub 2013 Apr 30.

PMID:
23642329
50.

Response of liver metastases to preoperative radiochemotherapy in patients with locally advanced rectal cancer and resectable synchronous liver metastases.

Manceau G, Brouquet A, Bachet JB, Penna C, El Hajjam M, Rougier P, Nordlinger B, Benoist S.

Surgery. 2013 Sep;154(3):528-35. doi: 10.1016/j.surg.2013.02.010. Epub 2013 Apr 16.

PMID:
23601902

Supplemental Content

Loading ...
Support Center